Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Cellectis> ?p ?o. }
Showing items 1 to 55 of
55
with 100 items per page.
- Cellectis abstract "Cellectis is a biopharmaceutical company focused on oncology. The company’s mission is to develop a novel generation of therapy based on engineered T-cells to treat cancer. Cellectis capitalizes on its 14 years of expertise in genome engineering, based on TALEN™, meganucleases and the state-of-the-art electroporation technology Pulse Agile, to create a new generation of cancer immunotherapy for treating leukemias and solid tumors. Cellectis adoptive cancer immunotherapy for chronic and acute leukemias is based on the first allogeneic T-cell chimeric antigen receptor (CAR) technology. CAR technologies are designed to target surface antigens expressed on cells. These treatments reduce toxicities associated with current chemotherapeutics and have the potential for curative therapy. The Cellectis Group is focused on life sciences and uses leading genome engineering technologies to build innovative products in various fields and markets. Cellectis is listed on the NYSE Alternext market (ticker: ALCLS). To find out more about us, visit our website: www.cellectis.com.".
- Cellectis foundingYear "1999".
- Cellectis keyPerson Andr%C3%A9_Choulika.
- Cellectis product Meganuclease.
- Cellectis product Nuclease.
- Cellectis wikiPageExternalLink www.cellectis-bioresearch.com.
- Cellectis wikiPageExternalLink www.cellectis.com.
- Cellectis wikiPageExternalLink www.sceil.com.
- Cellectis wikiPageID "30701834".
- Cellectis wikiPageRevisionID "606198615".
- Cellectis director André_Choulika.
- Cellectis foundation "1999".
- Cellectis hasPhotoCollection Cellectis.
- Cellectis homepage www.cellectis.com.
- Cellectis industry "biopharmaceutical company focused on oncology".
- Cellectis keyPeople "André Choulika, David Sourdive".
- Cellectis location "Paris XIIIème , Gothenburg , New Brighton United States".
- Cellectis logo File:Cellectis_logo.png.
- Cellectis products "Nucleases : TALEN™, meganuclease".
- Cellectis stockOption "--02-07".
- Cellectis type "French Société anonyme corporation with board of directors".
- Cellectis subject Category:Biotechnology_companies_of_France.
- Cellectis subject Category:Companies_established_in_1999.
- Cellectis subject Category:Companies_listed_on_the_Euronext_exchanges.
- Cellectis subject Category:Companies_of_France.
- Cellectis type Abstraction100002137.
- Cellectis type BiotechnologyCompanies.
- Cellectis type CompaniesEstablishedIn1999.
- Cellectis type CompaniesOfFrance.
- Cellectis type Company108058098.
- Cellectis type Group100031264.
- Cellectis type Institution108053576.
- Cellectis type Organization108008335.
- Cellectis type SocialGroup107950920.
- Cellectis type YagoLegalActor.
- Cellectis type YagoLegalActorGeo.
- Cellectis type YagoPermanentlyLocatedEntity.
- Cellectis type Agent.
- Cellectis type Company.
- Cellectis type Organisation.
- Cellectis type Organization.
- Cellectis type Agent.
- Cellectis type SocialPerson.
- Cellectis type Thing.
- Cellectis comment "Cellectis is a biopharmaceutical company focused on oncology. The company’s mission is to develop a novel generation of therapy based on engineered T-cells to treat cancer. Cellectis capitalizes on its 14 years of expertise in genome engineering, based on TALEN™, meganucleases and the state-of-the-art electroporation technology Pulse Agile, to create a new generation of cancer immunotherapy for treating leukemias and solid tumors.".
- Cellectis label "Cellectis".
- Cellectis label "Cellectis".
- Cellectis sameAs Cellectis.
- Cellectis sameAs m.0g9z463.
- Cellectis sameAs Q2943995.
- Cellectis sameAs Q2943995.
- Cellectis sameAs Cellectis.
- Cellectis wasDerivedFrom Cellectis?oldid=606198615.
- Cellectis homepage www.cellectis.com.
- Cellectis isPrimaryTopicOf Cellectis.